These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27644565)

  • 1. Assay of serum E2 concentration in postmenopausal breast cancer patients using a high-sensitivity RIA method is generally useful.
    Morimoto M; Takahashi M; Honda J; Yoshida T; Yoshida M; Toba H; Imoto I; Tangoku A; Sasa M
    J Med Invest; 2016; 63(3-4):236-40. PubMed ID: 27644565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.
    Santen RJ; Demers L; Ohorodnik S; Settlage J; Langecker P; Blanchett D; Goss PE; Wang S
    Steroids; 2007 Jul; 72(8):666-71. PubMed ID: 17588628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients.
    Kunovac Kallak T; Baumgart J; Stavreus Evers A; Sundström Poromaa I; Moby L; Kask K; Norjavaara E; Kushnir MM; Bergquist J; Nilsson K
    Climacteric; 2012 Oct; 15(5):473-80. PubMed ID: 22324859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of estrone sulfate in postmenopausal women: comparison of direct RIA and GC-MS/MS methods for monitoring response to endocrine therapy in women with breast cancer.
    Stanway SJ; Purohit A; Reed MJ
    Anticancer Res; 2007; 27(4C):2765-7. PubMed ID: 17695445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of steroids in rats after exposure to an endocrine disruptor: mass spectrometry and radioimmunoassay demonstrate similar results.
    Riffle BW; Henderson WM; Laws SC
    J Pharmacol Toxicol Methods; 2013; 68(3):314-22. PubMed ID: 23871967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures.
    Santen RJ; Lee JS; Wang S; Demers LM; Mauras N; Wang H; Singh R
    Steroids; 2008 Dec; 73(13):1318-21. PubMed ID: 18614192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement.
    Faltinová M; Vehmanen L; Lyytinen H; Haanpää M; Hämäläinen E; Tiitinen A; Blomqvist C; Mattson J
    Breast Cancer Res Treat; 2023 Oct; 201(3):425-435. PubMed ID: 37491651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens.
    Faupel-Badger JM; Fuhrman BJ; Xu X; Falk RT; Keefer LK; Veenstra TD; Hoover RN; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):292-300. PubMed ID: 20056650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.
    Wang Q; Rangiah K; Mesaros C; Snyder NW; Vachani A; Song H; Blair IA
    Steroids; 2015 Apr; 96():140-52. PubMed ID: 25637677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
    Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between radioimmunoassay and high performance liquid chromatography tandem-mass spectrometry for the analysis of androstenedione.
    Bruce SJ; Rey F; Béguin A; Berthod C; Werner D; Henry H
    Anal Biochem; 2014 Jun; 455():20-5. PubMed ID: 24708936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.
    Janse F; Eijkemans MJ; Goverde AJ; Lentjes EG; Hoek A; Lambalk CB; Hickey TE; Fauser BC; Norman RJ
    Eur J Endocrinol; 2011 Dec; 165(6):925-33. PubMed ID: 21969522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, validation and comparison of LC-MS/MS and RIA methods for quantification of vertebrates-like sex-steroids in prosobranch molluscs.
    Gust M; Vulliet E; Giroud B; Garnier F; Couturier S; Garric J; Buronfosse T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1487-92. PubMed ID: 20399713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol.
    Kushnir MM; Rockwood AL; Bergquist J; Varshavsky M; Roberts WL; Yue B; Bunker AM; Meikle AW
    Am J Clin Pathol; 2008 Apr; 129(4):530-9. PubMed ID: 18343779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.
    Hubalek M; Oberguggenberger A; Beer B; Meraner V; Sztankay M; Oberacher H; Schubert B; Wildt L; Seeber B; Giesinger J; Kemmler G; Holzner B; Sperner-Unterweger B
    Clin Breast Cancer; 2014 Aug; 14(4):291-6. PubMed ID: 24468298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methods to measure low serum estradiol levels in postmenopausal women.
    Lee JS; Ettinger B; Stanczyk FZ; Vittinghoff E; Hanes V; Cauley JA; Chandler W; Settlage J; Beattie MS; Folkerd E; Dowsett M; Grady D; Cummings SR
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3791-7. PubMed ID: 16882749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive, simple and robust LC-MS/MS method for the simultaneous quantification of seven androgen- and estrogen-related steroids in postmenopausal serum.
    Ke Y; Bertin J; Gonthier R; Simard JN; Labrie F
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():523-34. PubMed ID: 25158021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurable Serum Estradiol and Estrone in Women 36-56 Years During Adjuvant Treatment With Aromatase Inhibitors for a Hormone Receptor-Positive Breast Cancer. Case Studies and Cross-sectional Study Using an Ultra-sensitive LC-MS/MS-Method.
    Van Houdt M; Han SN; Pauwels S; Billen J; Neven P
    Clin Breast Cancer; 2023 Jan; 23(1):84-90. PubMed ID: 36376236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Serum Levels of 3,3',5'-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay.
    Sakai H; Nagao H; Sakurai M; Okumura T; Nagai Y; Shikuma J; Ito R; Imazu T; Miwa T; Odawara M
    PLoS One; 2015; 10(10):e0138864. PubMed ID: 26426328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do metabolites account for higher serum steroid hormone levels measured by RIA compared to mass spectrometry?
    Stanczyk FZ; Xu X; Sluss PM; Brinton LA; McGlynn KA
    Clin Chim Acta; 2018 Sep; 484():223-225. PubMed ID: 29852126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.